These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1282711

  • 1. [Preliminary clinical evaluation of systemic chemotherapy of invasive cancer of the bladder by the CMV protocol].
    Szymanowski J, Koźmińska E, Malewski A, Stokłosa A.
    Pol Tyg Lek; ; 47(24-26):525-7. PubMed ID: 1282711
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N.
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [Abstract] [Full Text] [Related]

  • 8. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD, Petrylak DP, Singh P, Bagiella E, O'Toole KM, Benson MC, Olsson CA.
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y, Kihara K.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Infiltrating tumors of the bladder. Local response to systemic platinum-based chemotherapy].
    Boccon-Gibod L, Adjiman S, Beuzeboc P, Steg A.
    Ann Urol (Paris); 1989 Nov; 23(4):285-8. PubMed ID: 2686541
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [Abstract] [Full Text] [Related]

  • 15. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
    Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    Ann Urol (Paris); 1993 Jan; 27(1):51-7. PubMed ID: 7682388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Neo-adjuvant M-VAC in the treatment of infiltrating bladder tumors].
    García Reboll L, Vera Donoso CD, Ruíz Cerdá JL, Pontones Moreno JL, Martínez Jabaloyas JM, Jiménez Cruz JF.
    Actas Urol Esp; 1994 Apr; 18(4):271-6. PubMed ID: 7976712
    [Abstract] [Full Text] [Related]

  • 20. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.